Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- BUSINESS NEWS IN BRIEF
September 2, 2002
- Korosho Resumes Debates on Production of Blood Products
September 2, 2002
- Janssen's Virtual Hallucination System Used Widely
September 2, 2002
- Human Tissue Transplantation GL Compiled by Society
September 2, 2002
- JPMA to Prepare Guidebook on Electronic Data Capture
September 2, 2002
- Monkasho Initiates Protein 3,000 Project
September 2, 2002
- CMIC to Expand Business in Response to New PAL
September 2, 2002
- REGULATORY NEWS IN BRIEF
September 2, 2002
- FJPWA Asks Korosho to Abolish Recording Lot Numbers
September 2, 2002
- BUSINESS NEWS IN BRIEF
August 26, 2002
- PRESS SEMINAR
August 26, 2002
- BULLETIN -1-
August 26, 2002
- WEBSITE NEWS
August 26, 2002
- GCP Revision to Follow PAL Amendment
August 26, 2002
- RESEARCH AND DEVELOPMENT NEWS IN BRIEF
August 26, 2002
- Outline of New NDA Reviewing Institution Revealed
August 26, 2002
- Large Product Line, Reasonable Prices in Drug Stores Are Appreciated: Survey
August 26, 2002
- Korosho to Beef Up Japanese Makers' R&D Competitiveness
August 26, 2002
- 90% of Public Think School Education on Drugs Is Necessary: PAJ Survey
August 26, 2002
- Korosho to Propose More Attractive R&D Taxation System
August 26, 2002
ページ
Adeno-associated virus (AAV) gene therapies have long been viewed as carrying only a minimal risk of insertional mutagenesis — a…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…